Skip to main content
. 2020 Nov 19;9(1):1844403. doi: 10.1080/2162402X.2020.1844403

Figure 1.

Figure 1.

PD-L1 staining (E1L3N, Cell signaling technology) in head and neck carcinoma sample shows a weak staining of the tumor component (t) contrasting with a strong staining of the immune component (i) located in the stroma. Pathologists have scored this case 15% by tumor proportion score (TPS) and 40 by combined positive score (CPS)